National Access Cannabis Provides Update on Growth of National Access Cannabis Medical

Press Release

Now with 111 pharmacies participating in NAC’s Medical Cannabis Management System, National Access Cannabis Medical continues to expand its base of partner pharmacies across Canada

OTTAWA, Oct. 22, 2018 – National Access Cannabis Corp. (“NAC” or the “Company”) (TSXV: META), a best practices leader in delivering secure, safe, and responsible access to legal cannabis in Canada today announced the signing of Pharmacy Cannabis Program Agreements with 70 pharmacies in Canada that will be participating in the National Access Cannabis Medical Inc. (“NACM”) Medical Cannabis Management System™ (“MCMS”) in addition to those announced in April 2018, bringing the total number of pharmacies working with NACM to 111.

“We see this as tremendous growth for NAC,” said Mark Goliger, CEO of NAC. “This unique pharmacy partnership is a key pillar of our diversified cannabis business. The medical cannabis market in Canada is forecast to surpass $2B by 2020 (Deloitte, 2018), and as experienced medical clinic operators, we’re excited to grow our medical division and broaden our ability to provide safe and responsible access to legal medical cannabis.”

“The pharmacy application of the Medical Cannabis Management System provides a structured process and opportunity for independent pharmacies to enhance their involvement in medical cannabis therapy, by utilizing resources provided by NACM,” explained Pram Sandhu, VP Medical Operations & Business Optimization. “It was designed with input from pharmacists, for pharmacists. We’re thrilled by the opportunity to work with our new pharmacy partners toward the collective goal of improving medical cannabis related patient care.”

MCMS provides pharmacies with a turnkey medical cannabis program for their patients and, when legally permissible, assistance with management of product sourcing and distribution. The MCMS program roll-out was recently initiated with the on-boarding of a pilot pharmacy, a 2-day educational event for healthcare providers, and plans for systematic training to be launched across partner pharmacies in Ontario, British Columbia, Alberta and Saskatchewan. NACM continues to negotiate with pharmacies across Canada and is on target to enter into agreements with more than 150 pharmacies by late 2018-early 2019.

NACM facilitates the safe and responsible use of medical cannabis by connecting patients with knowledgeable healthcare practitioners, coordinating clinic visits, managing medical cannabis education, providing assistance with product selection, coordinating patient registration with Health Canada approved Licensed Producers (LPs) and continued patient follow-up. After an initial on-boarding period, NACM anticipates assisting more than 200 potential medical cannabis patients per pharmacy per year, through its current roster of 111 partner pharmacies.

About National Access Cannabis Corp.

NAC is a best practices leader in delivering secure, safe, and responsible access to legal cannabis in Canada. Through its Canada-wide network of medical cannabis clinics, partner pharmacies, NAC Bio’s clinical research division, NewLeaf Cannabis™ and Meta Cannabis Supply Co.™ recreational cannabis retail stores, NAC enables patients and the public to gain knowledge and access to Canada’s network of authorized Licensed Producers of cannabis. NAC is listed on the TSX Venture Exchange under the symbol (TSXV: META).

For more information, visit:

www.nacmedical.com
www.nationalaccesscannabis.com
www.nacbio.com
www.metacannabis.com
www.newleafcannabis.ca

For further information: National Access Cannabis: Mark Goliger, Chief Executive Officer, National Access Cannabis, 1-800-411-1126, Info@nationalaccesscannabis.com; Investor Relations: Emily Gibbs, LodeRock Advisors Inc., 416-546-8775, emily.gibbs@loderockadvisors.com; Media Inquiries: Jessica Patriquin, 416.640.5525 x 230, M 416.995.8496, E jessicap@wearemaverick.com

IBF4